Beam Therapeutics BEAM

$ 25.05 -0.28%

Quarterly report 2024-Q2
added 08-06-2024

Beam Therapeutics Balance Sheet 2011-2024 | BEAM

Annual Balance Sheet Beam Therapeutics

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-263 M	-53.8 M	-549 M	-153 M	-5.98 M	-146 M	-1.9 M	-	-	-	-	-	-
Long Term Debt	160 M	169 M	3.01 M	5.29 M	4.41 M	-	-	-	-	-	-	-	-
Long Term Debt Current	12.8 M	10.4 M	7.54 M	4.22 M	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	26 M	7.4 M	20 K	-	-	-	-	-	-
Total Current Liabilities	206 M	224 M	213 M	102 M	-	-	-	-	-	-	-	-	-
Total Liabilities	478 M	608 M	648 M	206 M	55.2 M	33 M	6.58 M	-	-	-	-	-	-
Deferred Revenue	68.7 M	136 M	86.3 M	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-1.19 B	-1.06 B	-768 M	-398 M	-203 M	-125 M	-9.46 M	-	-	-	-	-	-
Total Assets	1.46 B	1.34 B	1.47 B	452 M	156 M	167 M	2.4 M	-	-	-	-	-	-
Cash and Cash Equivalents	436 M	233 M	560 M	162 M	37.2 M	148 M	-	-	-	-	-	-	-
Book Value	981 M	733 M	827 M	246 M	101 M	134 M	-4.18 M	-	-	-	-	-	-
Total Shareholders Equity	981 M	733 M	827 M	246 M	-201 M	-117 M	-	-	-	-	-	-	-

All numbers in USD currency

Quarterly Balance Sheet Beam Therapeutics

	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	153 M	156 M	160 M	304 K	875 K	983 K	1.15 M	1.39 M	1.79 M	2.4 M	3.01 M	3.6 M	4.18 M	4.74 M	5.29 M	5.29 M	5.29 M	5.29 M	4.41 M	4.41 M	4.41 M	4.41 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	407 M	446 M	478 M	512 M	542 M	571 M	608 M	636 M	618 M	624 M	648 M	303 M	345 M	271 M	206 M	206 M	206 M	206 M	55.2 M	55.2 M	55.2 M	55.2 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	84.9 M	72.1 M	68.7 M	153 M	139 M	143 M	136 M	160 M	140 M	115 M	86.3 M	12.8 M	10 M	-	24 K	24 K	24 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-1.38 B	-1.29 B	-1.19 B	-1.33 B	-1.24 B	-1.15 B	-1.06 B	-1.02 B	-909 M	-837 M	-768 M	-704 M	-675 M	-599 M	-398 M	-398 M	-398 M	-398 M	-203 M	-203 M	-203 M	-203 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	1.26 B	1.36 B	1.46 B	1.29 B	1.35 B	1.33 B	1.34 B	1.35 B	1.42 B	1.45 B	1.47 B	1.16 B	893 M	693 M	452 M	452 M	452 M	452 M	156 M	156 M	156 M	156 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	293 M	288 M	436 M	169 M	226 M	250 M	233 M	157 M	266 M	297 M	560 M	612 M	212 M	97.2 M	177 M	162 M	162 M	162 M	37.2 M	37.2 M	37.2 M	37.2 M	148 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	854 M	913 M	981 M	779 M	812 M	762 M	733 M	714 M	800 M	829 M	827 M	854 M	549 M	422 M	246 M	246 M	246 M	246 M	101 M	101 M	101 M	101 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	854 M	913 M	981 M	779 M	812 M	762 M	733 M	714 M	800 M	829 M	827 M	854 M	549 M	422 M	246 M	246 M	246 M	246 M	-201 M	-201 M	-201 M	-201 M	-117 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency